4D Molecular Therapeutics Inc (FDMT)
25.64
+0.06
(+0.23%)
USD |
NASDAQ |
May 16, 16:00
25.66
+0.02
(+0.08%)
After-Hours: 20:00
4D Molecular Therapeutics Revenue (Quarterly): 0.028M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.028M |
| December 31, 2023 | -0.019M |
| September 30, 2023 | 20.20M |
| June 30, 2023 | 0.239M |
| March 31, 2023 | 0.298M |
| December 31, 2022 | 1.247M |
| September 30, 2022 | 0.50M |
| June 30, 2022 | 0.162M |
| March 31, 2022 | 1.219M |
| December 31, 2021 | 0.092M |
| Date | Value |
|---|---|
| September 30, 2021 | 1.366M |
| June 30, 2021 | 14.58M |
| March 31, 2021 | 2.00M |
| December 31, 2020 | -0.977M |
| September 30, 2020 | 7.421M |
| June 30, 2020 | 3.633M |
| March 31, 2020 | 3.535M |
| December 31, 2019 | 2.03M |
| September 30, 2019 | 0.54M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.977M
Minimum
Dec 2020
20.20M
Maximum
Sep 2023
3.058M
Average
1.219M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 119.50M |
| NovaBay Pharmaceuticals Inc | 2.631M |
| Palatin Technologies Inc | 2.034M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.40M |
| Total Expenses (Quarterly) | 38.16M |
| EPS Diluted (Quarterly) | -0.66 |
| Enterprise Value | 799.76M |
| Profit Margin (Quarterly) | -115.7K% |
| Earnings Yield | -9.52% |
| Normalized Earnings Yield | -9.516 |